Previous Article | Next Article ![]()
Infection and Immunity, August 2000, p. 4574-4577, Vol. 68, No. 8
Department of Molecular Immunology, School of
Agriculture and Life Sciences, University of Tokyo, Tokyo
113,1 Laboratory of Immunology, Central
Institute for Experimental Animals, Kawasaki, Kanagawa
216,2 and 8th Laboratory, Kanagawa
Academy of Science and Technology, Kawasaki, Kanagawa
213,3 Japan, and Department of
Microbiology/Immunology, University of Health Science, Chicago
Medical School, North Chicago, Illinois 600644
Received 2 September 1999/Returned for modification 28 October
1999/Accepted 12 May 2000
One of the most characteristic clinical features in cutaneous
leishmaniasis is the development of nodules followed by ulcerations at
the site of infection. Leishmania amazonensis-infected mice show similar ulcerative lesions. Leishmania-infected severe
combined immunodeficiency (SCID) mice, however, have been shown
to develop nonulcerative nodules. In the present study, the
roles of T cells in ulceration were examined using SCID mice in cell
reconstitution experiments. After development of nonulcerative nodules,
SCID mice were inoculated with splenocytes from either
Leishmania-infected or naive immunocompetent mice,
resulting in ulceration in all mice. When naive splenocytes were
depleted of CD4+, CD8+, or B220+
cell populations and the remaining cells were injected into
Leishmania-infected SCID mice after the development of
nodules, only SCID mice inoculated with
splenocytes depleted of CD4+ cells did not show ulceration.
The evidence obtained in this study clearly
shows that the CD4+ cell population is indispensable for
ulceration in leishmaniasis lesions of SCID mice.
Leishmaniasis is a complex disease
with differing symptoms, including cutaneous, mucocutaneous, and
visceral manifestations, and is one of the most widespread disease in
tropical and subtropical countries. A hallmark of cutaneous
leishmaniasis is the development of papules or nodules followed by
ulceration at the site of promastigote infection. Cutaneous
leishmaniasis, while not fatal, produces long-lasting ulcers and leaves
scars upon healing.
Leishmaniasis is caused by obligate intracellular protozoan parasites
of the genus Leishmania which replicate inside the
parasitophorous vacuoles of infected macrophages. Most experimental
investigations of leishmaniasis so far have focused almost exclusively
on the cellular and molecular mechanisms involved in controlling
protozoan proliferation. In this context, CD4+ T cells have
been shown to play important roles in protection against
Leishmania major infection (11, 12, 19).
The roles of CD4+ T cells in pathological changes in
cutaneous leishmaniasis are not well understood, although they are
known to be predominant inducers of pathological changes in other
infectious diseases (1, 5, 8, 13). The recent increase of
unusual clinical features in patients coinfected with human
immunodeficiency virus (HIV) such as nonulcerative cutaneous lesions
(3, 5, 16) has prompted us to investigate the role of
CD4+ T cells in pathological changes in cutaneous
leishmaniasis. In the present study, we demonstrate that
CD4+ cells are indispensable for ulcer development in
L. amazonensis-infected SCID mice.
Mice.
C.B-17/lcrJcl-scid (SCID), C.B-17/lcrJcl
(C.B-17), and BALB/cAJcl (BALB/c) were bred and housed in the
specific-pathogen-free animal care facility of the Central Institute
for Experimental Animals, Kanagawa, Japan. Age (8-week-old)- and sex
(male)-matched mice were used throughout the experiments.
Parasite infection.
Promastigotes of L. amazonensis (MPRO/BR/72/M1845) were cultured at 23°C in medium
199 (Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) supplemented with
10% heat-inactivated fetal bovine serum (FBS). The organisms were
harvested from stationary-phase cultures, centrifuged, and washed with
Hanks' balanced salt solution (HBSS) (Nissui Pharmaceutical Co.,
Ltd.). Mice were inoculated with 107 infective
promastigotes subcutaneously at the base of the tail. Lesion
development was visually monitored by weekly measurement with a
direct-reading vernier caliper gauge and was expressed as the
dimensions of the nodule base (width by length).
Cell preparation and adoptive transfer of immunocompetent
cells.
For transfusion of splenocytes, spleens were removed
aseptically from naive or L. amazonensis-infected C.B-17
mice at week 10 after infection. Spleens were minced and passed through
a sterile nylon 200-mesh screen. Red blood cells were lysed using 144 mM NH4Cl solution. The splenocytes were washed and
suspended in HBSS, and 0.5 ml of the suspension containing
107 or 108 cells was transferred
intraperitoneally into L. amazonensis-infected SCID mice at
week 10 after infection.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
CD4+ Cells Are Indispensable for Ulcer
Development in Murine Cutaneous Leishmaniasis

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Histopathological examination. For histopathological examinations, mice were euthanized at days 8 and 12 after transfer of immunocompetent naive splenocytes, and the skin lesions were removed from the SCID mice. Half of each tissue sample was fixed using 10% buffered formalin and was embedded in paraffin. The block was then sectioned at 5-µm thickness and stained with hematoxylin-eosin.
| |
RESULTS |
|---|
|
|
|---|
Development of skin lesions in C.B-17 and SCID mice. The nodules in both C.B-17 and SCID mice appeared by week 3 after infection and enlarged thereafter, showing no signs of resolving. There was no significant difference between lesion sizes in C.B-17 and SCID mice until week 10 after infection (data not shown). In the lesions in C.B-17 mice, an ulcer was formed at the top of the nodule by week 6 after infection, whereas lesions of SCID mice exhibited quite a different appearance. Cutaneous lesions of SCID mice did not form any ulcers and increased in height until week 10 after infection. Since SCID mice lack functional T and B cells, it was suggested that these cells might be essential for ulcer formation in cutaneous leishmaniasis.
Ulcer formation in L. amazonensis-infected SCID mice
inoculated with immunocompetent splenocytes.
At week 10 after
infection with L. amazonensis, naive or L. amazonensis-infected C.B-17 splenocytes were intraperitoneally transferred into infected SCID mice. Nodules of the SCID mice which
received 107 splenocytes from C.B-17 mice infected with
L. amazonensis were ulcerated on day 8 after transfer (Fig.
1). In SCID mice which were inoculated
with the same number of naive C.B-17 splenocytes, ulceration occurred
on day 12 after transfer.
|
Histopathological changes in the skin lesions after splenocytes inoculation. As we reported previously (21), in ulcerated nodules of C.B-17 mice, the epidermis had been desquamated and the dermis was infiltrated with mononuclear and polymorphonuclear cells. The subcutaneous tissue was infiltrated with mononuclear and polymorphonuclear cells as well as vacuolated histiocytes which contained many amastigotes. Nonulcerated nodules of SCID mice appeared to differ from ulcerated nodules of C.B-17 mice. In nodules of SCID mice, the epidermis was thickened, and the dermis was infiltrated with few mononuclear and polymorphonuclear cells. In the subcutaneous tissue, there was an accumulation of vacuolated histiocytes containing a large number of amastigotes, although few mononuclear and polymorphonuclear cells were observed.
After the transfer of immunocompetent naive splenocytes to infected SCID mice on day 8, when the ulcer had not yet formed, the epidermis and dermis did not appear to differ from those of the animals before transfer (Fig. 2A). In the subcutaneous tissue, however, in addition to the accumulation of vacuolated histiocytes containing a large number of amastigotes, some areas were infiltrated with both mononuclear and polymorphonuclear cells, suggesting the occurrence of cellular reactions (Fig. 2A, inset).
|
Ability of CD4+ cells, CD8+ cells, or B220+ cells to induce ulcer formation in leishmaniasis. To analyze which type of cell population in immunocompetent splenocytes can trigger the necrotic responses in leishmaniasis cutaneous lesions, we examined the ability of naive splenocytes depleted of CD4+, CD8+, or B220+ cells to induce ulcers in cutaneous lesions. The efficacy of depletion was assessed by flow cytometry analysis. The proportion of cells remaining after the depletion of each subpopulation was 0.8% for CD4+ cells, 0.2% for CD8+ cells, and 0.8% for B220+ cells in a typical experiment. The remaining subpopulations of cells were transferred into L. amazonensis-infected SCID mice.
Figure 3 shows the course of ulcer formation in the nodules of SCID mice which were inoculated with various cells on week 13 after infection with L. amazonensis. The leishmaniasis nodules in SCID mice inoculated with naive splenocytes depleted of CD8+ cells became reddish on day 8 after transfer, and on day 10 after transfer, ulcers developed at the tops of the nodules in all mice. SCID mice inoculated with naive splenocytes depleted of B220+ cells or nontreated naive splenocytes showed the reddish nodules on day 8 to 9 after transfer, and on day 11 after transfer, all the mice showed ulcer formation. In contrast, SCID mice inoculated with naive splenocytes depleted of CD4+ cells did not form ulcers at the lesions even at day 30 after transfer and instead had nonulcerated lesions similar to those of nontreated L. amazonensis-infected SCID mice. None of the lesions of SCID mice inoculated with various cells showed any signs of healing until the end of the experiment (30 days after transfer).
|
| |
DISCUSSION |
|---|
|
|
|---|
The pivotal role of CD4+ T cells in liver granuloma formation has been thoroughly documented in both listeriosis and mycobacteriosis (8, 13). Consistently, it has been reported that SCID mice infected with L. donovani or Schistosoma mansoni could not form granuloma in liver lesions (1, 5). In L. amazonensis infection, even in the absence of T and B cells, SCID mice developed cutaneous nodules consisting mainly of vacuolated macrophages containing amastigotes. This finding suggests T-cell-independent mechanisms of macrophage accumulation in cutaneous leishmaniasis in contrast to T-cell-dependent macrophage accumulation observed in visceral leishmaniasis (10).
The formation of nonulcerative nodules in SCID mice after the infection with L. amazonensis is consistent with previous reports using L. major (7, 23) and suggests that ulcer formation in cutaneous nodules in leishmaniasis is a lymphocyte-dependent reaction. Therefore, we investigated lymphocyte subsets which might play pivotal roles in ulcer formation using a SCID mouse model. Previous work using SCID mice has shown the relative ease of reconstitution of the immune system with immunocompetent splenocytes containing functional T and B cells (23). Hence, we examined the ability of immunocompetent splenocytes to induce ulcer formation in cutaneous leishmaniasis lesions by transferring them into L. amazonensis-infected SCID mice. After the transfer of either naive or sensitized immunocompetent splenocytes, ulceration was observed in the nodules of infected SCID mice. The ability of immunocompetent splenocytes to induce ulceration was abolished only when CD4+ cells were depleted. These results strongly suggest that the addition of immunocompetent splenocytes is sufficient to induce ulcers in cutaneous leishmaniasis lesions in SCID mice and that CD4+ cells are indispensable for ulcer formation.
A heavy accumulation of mononuclear cells was noted in the SCID lesions after transfer of immunocompetent splenocytes. In L. major-infected SCID mice reconstituted with a T-cell line, migration of donated cells to the sites of infection was observed (9). In murine cutaneous leishmaniasis caused by L. mexicana, a selective accumulation of T cells in the cutaneous lesions has also been reported (18). Taken together, our observations also suggest migration of CD4+ cells to the lesions. Although expression of cytokines at the local site of infection was not investigated in this study, expression of certain cytokines was detected in the cutaneous lesions (unpublished data). Therefore, the transferred cells might trigger the ulcer development directly by secreting cytokines and/or indirectly by affecting other cells at the site of infection.
Recently, Soong et al. (20) reported that L. amazonensis infection caused no cutaneous lesions in the C57BL/6J mice with targeted disruption of the major histocompatibility complex class II gene or recombination-activating gene 2. The differences between the findings and our results are of interest. One critical difference is that the two studies used mice with different genetic backgrounds. We previously reported that recombination-activating gene 2 knockout mice with BALB/c background developed cutaneous lesions when infected with L. amazonensis (21). Furthermore, Soong et al. inoculated the parasites into the footpad (20). Sites of infection may be related to the susceptibility of animals (14). Therefore, the different routes of infection used might lead to the different results seen.
The typical clinical aspects of cutaneous leishmaniasis are the development of nodules and ulcer formation at the site of infection. Recently, however, human leishmaniasis with nonulcerative cutaneous lesions has been reported (6, 16). HIV in AIDS patients reduces the CD4+ T-cell number (14). The present data may explain the nonulcerative cutaneous lesions in human cases of Leishmania and HIV double infection. Nonulcerative cutaneous lesions have also been reported in diffuse cutaneous leishmaniasis (DCL) patients who are infected with L. mexicana complex including L. amazonensis (4). The lesions in DCL patients with numerous nonulcerative lesions with high numbers of parasites and few lymphocytes (4) are similar to the lesions observed in the mice lacking functional T cells (21, 22). Moreover, DCL patients are characterized by the lack of helper T-cell responses against Leishmania antigen (2, 15). Since SCID mice are deficient for functional T cells, they do not have any T-cell responses against Leishmania antigens. The present data from cell transfer experiments in which the SCID mice showed ulcer formation only when they received splenocytes with CD4+ cells may suggest pivotal roles of CD4+ cells in formation of nonulcerative nodules in DCL patients.
In conclusion, when L. amazonensis-infected SCID mice received immunocompetent splenocytes intraperitoneally, nonulcerative cutaneous lesions ulcerated. However, only when splenocytes depleted of CD4+ cells were transferred did ulceration fail to occur at the cutaneous nodules of SCID mice. Therefore, CD4+ cells appear to be indispensable for ulcer formation in cutaneous lesions of leishmaniasis in SCID mice.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Grants-in-Aid for Scientific Research (B) (08456149) and for Scientific Research (A) (10041190) from the Ministry of Education, Sciences, Culture, and Sports, Japan.
We thank K. Hioki and S. Endo for supplying the animals, and U. A. K. Kara and D. Jankovic for critically reviewing the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Molecular Immunology, School of Agriculture and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. Phone: 81-3-5841-5197. Fax: 81-3-5841-8020. E-mail: aysmatsu{at}mail.ecc.u-tokyo.ac.jp.
Present address: Molecular Immunogenetics and Vaccine Research
Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Amiri, P.,
R. M. Locksley,
T. G. Parslow,
M. Sadick,
E. Rector,
D. Ritter, and J. H. McKerrow.
1992.
Tumor necrosis factor restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice.
Nature
356:604-607[CrossRef][Medline].
|
| 2. |
Castes, M.,
M. Cabrera,
D. Trujillo, and J. Convit.
1988.
T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis.
J. Clin. Microbiol.
26:1207-1213 |
| 3. | Cnudde, F., C. Raccurt, F. Boulard, B. Teron-Aboud, M. Nicolas, and B. Juminer. 1994. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. AIDS 8:559-560[Medline]. |
| 4. | Convit, J., M. E. Pinardi, and A. J. Rondon. 1972. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans. R. Soc. Trop. Med. Hyg. 66:603-610[CrossRef][Medline]. |
| 5. |
Curry, A. J., and P. M. Kaye.
1992.
Recombinant interleukin-1 augment granuloma formation and cytokine production but not parasite clearance in mice infected with Leishmania donovani.
Infect. Immun.
60:4422-4426 |
| 6. | Da-Cruz, A. M., E. S. Machado, J. A. Menezes, M. S. Rutowitsch, and S. G. Coutinho. 1992. Cellular and humoral immune responses of a patient with American leishmaniasis and AIDS. Trans. R. Soc. Trop. Med. Hyg. 86:511-512[CrossRef][Medline]. |
| 7. | Guy, R. A., and M. Belosevic. 1995. Response of scid mice to establishment of Leishmania major infection. Clin. Exp. Immunol. 100:440-445[Medline]. |
| 8. |
Hänsch, H. C. R.,
D. A. Smith,
M. E. A. Mielke,
H. Hahn,
G. J. Bancroft, and S. Ehlers.
1996.
Mechanisms of granulona formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.
Int. Immunol.
8:1299-1310 |
| 9. | Holaday, B. J., M. D. Sadick, Z. Wang, S. L. Reiner, F. P. Heinzel, T. G. Parslow, and R. M. Locksley. 1991. Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. J. Immunol. 147:1653-1658[Abstract]. |
| 10. |
Kay, P. M., and G. J. Bancroft.
1992.
Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro.
Infect. Immun.
60:4335-4342 |
| 11. | Liew, F. Y., and C. A. O'Donnell. 1993. Immunology of leishmaniasis. Adv. Parasitol. 32:161-259[Medline]. |
| 12. | Locksley, R. M., and P. Scott. 1991. Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunol. Today 12:A58-A61[CrossRef][Medline]. |
| 13. |
Mielke, M. E. A.,
S. Ehlers, and H. Hahn.
1988.
T-cell subsets in delayed-type hypersensitivity, protection and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.
Infect. Immun.
56:1920-1925 |
| 14. |
Nabors, G. S., and J. P. Farrell.
1994.
Site-specific immunity to Leishmania major in SWR mice: the site of infection influences susceptibility and expression of the antileishmanial immune response.
Infect. Immun.
62:3655-3662 |
| 15. | Petersen, E. A., F. A. Neva, A. Barral, R. Correa-Coronas, H. Bogaert-Diaz, D. Martinez, and F. E. Ward. 1984. Monocyte suppression of antigen-specific lymphocyte responses in diffuse cutaneous leishmania patients from the Dominican republic. J. Immunol. 132:2603-2606[Abstract]. |
| 16. | Pharoah, P. D. P., J. M. Ponnighaus, D. Chavula, and S. B. Lucas. 1993. Two cases of cutaneous leishmaniasis in Malawi. Trans. R. Soc. Trop. Med. Hyg. 87:668-670[CrossRef][Medline]. |
| 17. | Rosenberg, Y. J., A. O. Anderson, and R. Pabst. 1998. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol. Today 19:10-17[CrossRef][Medline]. |
| 18. | Sánchez, M. A., G. Cáceres-Dittmar, O. Oriol, W. Mosca, G. Kraal, and F. J. Tapia. 1993. Epidermal Langerhans cells and dendritic epidermal T cells in murine cutaneous leishmaniasis. Immunocytochemical study. Acta Microscopica 2:180-187. |
| 19. |
Scott, P.
1991.
IFN- modulates the early development of Th1 and Th2 responses in a murine models of cutaneous leishmaniasis.
J. Immunol.
147:3149-3155[Abstract].
|
| 20. | Soong, L., C.-H. Chang, J. Sun, B. J. Longley, N. H. Ruddle, R. A. Flavell, and D. McMahon-Pratt. 1997. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158:5374-5383[Abstract]. |
| 21. | Terabe, M., T. Kuramochi, T. Hatabu, M. Ito, Y. Ueyama, K. Katakura, S. Kawazu, T. Onodera, and Y. Matsumoto. 1998. Non-ulcerative cutaneous lesion in immunodeficient mice with Leishmania amazonensis infection. Parasitol. Inter. 48:47-53. |
| 22. | Terabe, M., T. Hatabu, H. Takahashi, M. Ito, T. Onodera, and Y. Matsumoto. 1999. Leishmania amazonensis infection in nude mice. Exp. Anim. 48:119-123[CrossRef][Medline]. |
| 23. | Varkila, K., R. Chatelain, L. M. Leal, and R. L. Coffman. 1993. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type 1 response and renders them capable of healing Leishmania major infection. Eur. J. Immunol. 23:262-268[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»